Description

Women in Medtech Forum: Leveraging Remote Stroke Technologies to Increase Access to Care 

MARCH 16TH | 8:00 - 10:00 AM

Siemens Healthineers Endovascular Robotics (formerly Corindus Vascular Robotics)
275 Grove Street, Newton (Auburndale), MA
 

According to the Office on Women's Health in the Office of the Assistant Secretary for Health at the U.S. Department of Health and Human Services, women are more likely to die of a stroke than men, impacting one out of every five women. Presenting with non-traditional stroke symptoms, women tend to have worse outcomes from a stroke than men due to increased risk factors such as hormones and co-morbidities that are more likely to occur in women.

When a stroke occurs, decreasing the time to intervention presents significant opportunities to improve patient outcomes and quality of life. This Women in Medtech Forum will focus on innovative solutions for stroke symptom monitoring and treatment, with a specific emphasis on increasing access to care. Industry leaders will join us for this informative discussion around the need for continued investments in stroke care, including remote surgical solutions under development and home health technology available to reduce the risk of an additional stroke. Register now to have a seat at the table for this important women’s health topic.

In-person registration is now sold out.
But free, virtual tickets are still available!

SPEAKERS

	Lana Caron, Sr. Director, Philips Ventures, Philips, North America Lana Caron serves as Sr. Director at Philips Ventures, the venture capital arm of Philips, where she leads venture investing and partnering activities in North America, including sourcing, due diligence, deal structuring, portfolio management and commercial development. She’s a strategic business development leader and venture investor with strengths in driving growth and innovation in health technology and established track record of success investing in groundbreaking technology, launching new ventures and expanding business into new markets. Lana has over 20 years of experience with increasing levels of responsibility in strategy, business development, innovation and commercialization across medtech, healthtech, digital and consumer health at both start-ups and large tech companies. Before joining Philips Ventures, Lana held leadership roles as VP of Sales & Marketing for an early-stage enterprise software start-up, Director of Corporate Development at Sensata Technologies (formerly Texas Instruments) and Manager of Strategy & Business Development at Philips Healthcare. Lana started her career in management consulting with Accenture. Based in Boston, Lana is an active startup advisor and board member currently serving on three company boards. She holds MS in Economics and MBA degrees and is a frequent speaker on venture capital, healthcare innovation and entrepreneurship.
	Dr. Raymond Dwight Turner, IV, MD, Prisma Health, CMO, Siemens Healthineers Endovascular Robotics (EVR) Raymond Turner is a board-certified Neurosurgeon and Neuro-Endovascular Surgeon at PRISMA Health - Greenville Memorial Hospital and Professor of Neurosurgery at University of South Carolina College of Medicine - Greenville. Dr. Turner completed his undergraduate degree in Biology at Sacred Heart University where he also played collegiate baseball. He went on to complete his medical degree in Poznan, Poland. Trained at the Cleveland Clinic in Neurological Surgery and fellowship trained in Endovascular Neurosurgery, Dr. Turner practiced at MUSC in Charleston SC for over 10 years prior to moving to PRISMA Health in 2018. While at MUSC, he assumed graduated responsibilities over his tenure, including Neurosurgery Residency Program Director and Chief of Neurosciences. Nationally, Dr. Turner also serves as a lead examiner for the American Board of Neurological Surgery. An avid researcher with expertise in device development, Dr. Turner has been an invited speaker at over 80 academic engagements and has over 140 peer-reviewed publications. He has participated in over 70 pre-clinical and clinical research studies. Dr. Turner has also been an invited teacher in over 50 hands-on national and international training courses. He has served on numerous advisory boards, including Corindus, with six start-up acquisitions in his tenure. A former medical director with JnJ’s neurovascular divison, Cerenovus, Dr. Turner is now Chief Medical Officer for Siemens Healthineers’ Endovascular Robotics business. Outside of practicing medicine, Dr. Turner has been outspoken about the benefits of physical fitness in educating school-aged children, which resulted in him being featured in the award-winning feature length documentary “The Motivation Factor.” Dr. Turner resides in Greenville, SC with his wife Magdalena, and three children Amelia, Karolina, and Raymond.
	Julie Pritchard-Hedtke, Vice President of Medical Affairs and Medical Education, Siemens Healthineers Endovascular Robotics (EVR)  Julie Pritchard-Hedtke is an Executive Life Sciences’ Professional at Siemens-Healthineers, Endovascular Robotics, based in Newton, Massachusettes. Julie graduated from Moorhead State University in Moorhead, MN with a Bachelors degree in Paralegal Studies and a minor in Accounting. She began her career in the legal industry where she spent almost 30 years representing Healthcare and Med Device companies. In Legal, she spent a significant time with med device companies building productivity initiatives and operational excellence. While in the legal industry, from 2015 - 2019, Julie served as Chief Practice Officer and Chief Operating Officer where she focused on strategic growth initiatives. Julie has been the Head of Medical Affairs and Global Education at Siemens Healthineers since 2020. As the Head of Medical Affairs, she oversees the development and implementation of strategy that governs the clinical and scientific communication with internal and external customers. Providing the highest quality of care to patients and ensuring that the medical staff is well-trained and knowledgeable is the highest priority for Julie. She is an advocate for patient safety and works to ensure that the medical centers are compliant with all applicable regulations. She is a leader in the medical community and is dedicated to providing the best possible care to all patients. Since joining Siemens-Healthineers, Julie has delivered more than 60 educational and training events focussed on driving endovascular robotics. Julie has authored numerous articles for educational publications, including the topic of global training for physicians and sales team members during the pandemic through remote technology. Julie has served as a mentor for female executives through various organizations including, Life Sciences Trainers and Educators Network, American Bar Association and Association of Legal Administrators. Outside of work Julie is an avid runner, where she has completed halfmarathons in over 30 states, with the goal of finishing all 50 states. Julie enjoys spending her free time traveling, boating and skiing with her family. Julie resides in Minneapolis, MN.
	Sandra Saldana, PhD, MBA, CEO & Co-Founder, Alva Health Dr. Sandra Saldana is the CEO and Co-Founder of Alva Health, a Yale University spinout and Techstars-backed company that is developing a wearable device for real-time stroke detection. She is responsible for execution of the company’s strategy and vision, fundraising and day-to-day operations, currently serving as Principal Investigator on a $1MM Phase II SBIR grant funded by the National Science Foundation. Dr. Saldana has led Alva Health through participation in several elite business accelerators and pitch competitions, and received 1st place at the 2021 Silicon Valley Boomer Venture Summit business plan competition, Top 4 Finalist in the inaugural MedTech Color pitch competition, and the Grand Prize of $350,000 out of over 1100 global applicants in the 2021 MedTech Innovator competition, the largest global accelerator for medical device startups. Before Alva Health, Dr. Saldana was Vice President of sales and account management at Brand Institute’s Boston office, the top branding agency in the pharmaceutical and medical device industries. In her role, she advised pharma, biotech and med device executives on strategic branding, marketing and communications initiatives, while being responsible for territory sales growth. Dr. Saldana completed a BA in Biological Sciences at Cornell University, a PhD in Cancer Biology at the University of Texas MD Anderson Cancer Center, and an MBA in Healthcare Management at the Yale School of Management.

SPONSORS